Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 620.61M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | - | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -19.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -19.00% |
| Dividend | N/A | Price/Book | EPS next 5Y | - | 52W High Chg | -58.00% | |
| Recommedations | - | Quick Ratio | - | Shares Outstanding | 23.29M | 52W Low Chg | 94.00% |
| Insider Own | - | ROA | - | Shares Float | - | Beta | - |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 26.65 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 595,260 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 43,778 | Change | 115.09% |
About 2seventy bio, Inc. Common Stock When-Issued
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2seventy bio, Inc.(NasdaqGS:TSVT.V) operates independently of bluebird bio, Inc. as of November 4, 2021.